Clinical Trial Update: Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

A Phase 3 trial update reports two schedules of infliximab maintenance therapy in Ankylosing Spondylitis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Association de Recherche Clinique en Rhumatologie | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED